Search research articles
Contact Us
Filters
Showing results (91-100 of 150) with videos related to
Page
of 15
Sort By:
The International Journal on Drug Policy
|
April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015
T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Nature Communications
|
February 21, 2024
A hybrid transistor with transcriptionally controlled computation and plasticity
Yang Gao, Yuchen Zhou, Xudong Ji, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2023
A Hybrid Transistor with Transcriptionally Controlled Computation and Plasticity
Yang Gao, Yuchen Zhou, Xudong Ji, et al.
Pain
|
July 24, 2019
Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study
Alexander Hincker, Karen Frey, Lesley Rao, et al.
Journal of Visualized Experiments : Jove
|
February 17, 2025
Translating Extracellular Electron Transfer Activities with Organic Electrochemical Transistors
Yang Gao, Yuchen Zhou, Xudong Ji, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 2020
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors
Haeseong Park, Kerry Williams, Nikolaos A Trikalinos, et al.
Frontiers in Oncology
|
August 22, 2024
Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization
Bita Kalaghchi, Semra Ince, Justin Barnes, et al.
Nurse Education in Practice
|
May 1, 2025
Navigating a nursing career four years after graduation: A qualitative descriptive study exploring drivers of staying amid wanting to leave
Daniel Terry, Liz Ryan, Jessica Elliott, et al.
Investigational New Drugs
|
August 7, 2012
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma
Andrea Wang-Gillam, Stacey Plambeck-Suess, Peter Goedegebuure, et al.
Journal of the National Cancer Institute
|
August 24, 2024
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B-Southwest Oncology Group 80702 (Alliance)
Justin C Brown, Chao Ma, Qian Shi, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 150) with videos related to
Sort By:
Page
of 15
The International Journal on Drug Policy
|
April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015
T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Nature Communications
|
February 21, 2024
A hybrid transistor with transcriptionally controlled computation and plasticity
Yang Gao, Yuchen Zhou, Xudong Ji, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2023
A Hybrid Transistor with Transcriptionally Controlled Computation and Plasticity
Yang Gao, Yuchen Zhou, Xudong Ji, et al.
Pain
|
July 24, 2019
Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study
Alexander Hincker, Karen Frey, Lesley Rao, et al.
Journal of Visualized Experiments : Jove
|
February 17, 2025
Translating Extracellular Electron Transfer Activities with Organic Electrochemical Transistors
Yang Gao, Yuchen Zhou, Xudong Ji, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 2020
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors
Haeseong Park, Kerry Williams, Nikolaos A Trikalinos, et al.
Frontiers in Oncology
|
August 22, 2024
Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization
Bita Kalaghchi, Semra Ince, Justin Barnes, et al.
Nurse Education in Practice
|
May 1, 2025
Navigating a nursing career four years after graduation: A qualitative descriptive study exploring drivers of staying amid wanting to leave
Daniel Terry, Liz Ryan, Jessica Elliott, et al.
Investigational New Drugs
|
August 7, 2012
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma
Andrea Wang-Gillam, Stacey Plambeck-Suess, Peter Goedegebuure, et al.
Journal of the National Cancer Institute
|
August 24, 2024
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B-Southwest Oncology Group 80702 (Alliance)
Justin C Brown, Chao Ma, Qian Shi, et al.
Page
of 15